AI Healthcare Regulations in Wyoming: A Comprehensive Guide

Quick Answer: Wyoming's Stance on AI in Healthcare

Wyoming lacks specific statutes or administrative rules governing artificial intelligence in healthcare settings. AI tools deployed in Wyoming clinical environments are regulated under existing frameworks for medical practice, patient data, and consumer protection.

Three layers apply simultaneously:

1. Federal device and data law. The FDA regulates AI and machine learning tools meeting the definition of a medical device or Software as a Medical Device (SaMD). HIPAA governs any AI system that touches protected health information (PHI) (45 CFR Part 160, 164).
2. Wyoming medical practice law. The Wyoming Medical Practice Act (W.S. 33-26-101 et seq.) sets the standard of care and professional conduct obligations, applying whether a physician uses a stethoscope or an AI diagnostic tool.
3. Wyoming Department of Health rules. Facility licensing, patient care standards, and data management requirements under Wyoming Administrative Rules apply to AI-driven workflows within licensed healthcare facilities.

Consult the Wyoming Legislature's session records and the Wyoming Department of Health for any emerging proposals or task forces.

Federal vs. State Oversight: Where AI Healthcare Regulations Begin

FDA: The Device Layer

The FDA is the primary federal regulator for AI tools functioning as medical devices. A cross-sectional analysis of FDA-authorized oncology AI/ML devices found that clinical evidence supporting these authorizations varies substantially in quality and scope (Litt H et al., Journal of Cancer Policy, 2026, PMID 42025919). A separate review of AI/ML orthopaedic devices found few FDA-approved tools have peer-reviewed validation studies (Bracken A et al., Clinical Orthopaedics and Related Research, 2025, PMID 41915013).

Providers deploying AI imaging tools, clinical decision support algorithms, or wearable-based monitoring systems in Wyoming must verify FDA 510(k) clearance, De Novo authorization, or PMA approval. The FDA's published guidance on AI/ML-based SaMD, including its action plan for iterative algorithm changes, is the controlling federal document. Consult the FDA's Digital Health Center of Excellence for current guidance.

HIPAA: The Data Layer

Any AI system that ingests, processes, or outputs PHI is a business associate or a covered entity function under HIPAA (45 CFR Part 160, 164). Business Associate Agreements (BAAs) with AI vendors must address how the vendor handles PHI used for model training, inference, and logging. Wyoming does not have a separate comprehensive health data privacy statute that adds requirements beyond HIPAA for covered entities, but consult the Wyoming Attorney General's Office to confirm current state law, since consumer data privacy legislation evolves quickly.

Wyoming Board of Medicine: The Professional Conduct Layer

The Wyoming Board of Medicine enforces the Medical Practice Act (W.S. 33-26-101 et seq.) and sets standards for physician conduct. Using an AI tool does not transfer professional responsibility. A physician relying on an AI diagnostic output without appropriate clinical judgment remains subject to Board discipline. Consult the Wyoming Board of Medicine directly for any technology-specific guidance it has issued.

Key Regulatory Areas for AI in Wyoming Healthcare

Data Privacy and Security

Wyoming's general consumer data privacy law, the Wyoming Consumer Protection Act (W.S. 40-12-101 et seq.), applies to deceptive or unfair practices involving consumer data. Wyoming enacted a consumer data privacy law (W.S. 40-12-501 et seq., effective July 1, 2024) that covers personal data broadly. Healthcare entities that are HIPAA-covered are largely exempted from that law for PHI, but AI applications touching non-PHI patient data, such as de-identified datasets used for model training, may fall under its scope. Consult the Wyoming Attorney General's Consumer Protection Unit for a current interpretation.

Patient Safety and Quality of Care

Wyoming's standard of care, defined by W.S. 33-26-101 et seq., requires a reasonably competent physician's actions under similar circumstances. AI tools, including large language models in radiology reporting (de Margerie-Mellon C et al., European Radiology, 2026, PMID 42009869), do not alter this standard. Physicians remain accountable for clinical decisions, as AI tools are instruments.

Professional Licensure and Scope of Practice

Wyoming licenses physicians, nurses, pharmacists, and other practitioners through separate boards. Consult the Wyoming Board of Medicine and the Wyoming State Board of Nursing for current positions or specific guidance. A non-licensed AI system cannot independently practice medicine. Any AI output driving a clinical decision must be reviewed and authorized by a licensed practitioner.

Liability and Accountability

Wyoming tort law governs malpractice claims. If an AI tool contributes to patient harm, liability analysis will consider the physician's reliance on the tool, the vendor's representations about its capabilities, and whether the tool was FDA-cleared for the use in question. Wyoming has no AI-specific liability statute. Consult a Wyoming-licensed healthcare attorney for risk allocation strategies in vendor contracts.

Informed Consent

Wyoming's informed consent requirements derive from common law and the Medical Practice Act (W.S. 33-26-101 et seq.). No Wyoming statute requires specific disclosure that AI was used in a patient's care. However, professional ethics guidance from the American Medical Association recommends transparency with patients when AI tools influence clinical decisions. Facilities should develop internal consent policies addressing AI use, particularly for diagnostic AI tools.

Wyoming's Approach to Data Governance and AI Ethics

Wyoming has not published state-level guidance on algorithmic bias, AI fairness, or AI ethics in healthcare. While the Wyoming Department of Health maintains data management policies for state programs, these do not address AI training data integrity or model governance. Consult the Wyoming Department of Health's Office of Data and Analytics for current policies.

In the absence of state-specific rules, the following frameworks apply by default:

Data accuracy and integrity. HIPAA's Security Rule (45 CFR Part 164, Subpart C) requires covered entities to protect the integrity of electronic PHI. This extends to AI systems processing PHI: outputs must be auditable and traceable.

Algorithmic bias. No Wyoming agency has issued guidance on algorithmic bias. The American Medical Association's ethical guidance on augmented intelligence (AMA Policy H-480.940) is the closest applicable professional standard for Wyoming physicians. Federal civil rights law, including Section 1557 of the Affordable Care Act, prohibits discrimination in health programs receiving federal funding, which can apply to biased AI outputs producing disparate patient outcomes.

Transparency and explainability. Wyoming law does not mandate explainability for AI clinical decisions. The Office of the National Coordinator for Health Information Technology (ONC) has issued guidance on transparency for clinical decision support tools under the 21st Century Cures Act, which applies federally.

Human oversight. The Medical Practice Act (W.S. 33-26-101 et seq.) implicitly requires human oversight by making licensed practitioners accountable for clinical decisions. No AI system can substitute for that accountability under current Wyoming law.

Comparison: AI Oversight Across Key Healthcare Functions in Wyoming

Future Outlook: Emerging Trends and Potential Regulatory Shifts in Wyoming

Federal Signals That Will Reach Wyoming

The National Institute of Standards and Technology (NIST) AI Risk Management Framework (NIST AI 100-1) is voluntary but is becoming a de facto standard for healthcare AI procurement. ONC's rules under the 21st Century Cures Act already impose transparency requirements on certain clinical decision support tools. FDA's evolving framework for predetermined change control plans will affect how AI vendors can update algorithms post-clearance. All of these apply in Wyoming as federal requirements or influential standards.

Generative AI and Large Language Models

The use of large language models in clinical documentation and radiology reporting is accelerating (de Margerie-Mellon C et al., European Radiology, 2026, PMID 42009869). Current Wyoming law has no specific rules for generative AI in clinical notes. The risks, including hallucinated clinical information entered into the medical record, fall under existing malpractice and medical records law. Wyoming healthcare facilities should develop internal governance policies now, before regulation catches up.

Wyoming Legislative Activity

Monitor the Wyoming Legislature's session bills at wyoleg.gov and the Wyoming Department of Health's rulemaking docket for any new proposals. Consult the Wyoming Governor's Office for announcements regarding any task forces or study commissions.

Voluntary Standards Becoming Requirements

Industry bodies including the Coalition for Health AI (CHAI) and the American College of Radiology's AI standards program are developing best-practice frameworks. Payers and health systems are beginning to require compliance with these frameworks in vendor contracts. Wyoming providers adopting these voluntary standards now will be better positioned when formal regulation arrives.

Next Steps for Healthcare Providers and Developers in Wyoming

Compliance Strategies

Inventory all AI tools in use, including vendor-supplied tools embedded in EHR systems. For each, confirm FDA clearance, review the BAA for HIPAA compliance, and document clinical workflows ensuring licensed practitioner review of AI outputs. This inventory serves as a baseline for regulatory inquiry.

Due Diligence for New AI Adoptions

Before contracting with an AI vendor, require FDA clearance documentation or a written explanation if the tool does not meet the device definition. Review peer-reviewed validation studies. Basu et al. (Inquiry, 2026, PMID 42012014) found technology performance claims in managed care procurement are often overstated; apply similar scrutiny to AI vendor claims.

Key Contacts

• Wyoming Board of Medicine: 320 West 25th Street, Suite 103, Cheyenne, WY 82002. Phone: (307) 778-7053. Website: wyomingboard.com. Contact for questions about physician use of AI tools and professional conduct standards.
• Wyoming Department of Health: 6101 Yellowstone Road, Cheyenne, WY 82002. Phone: (307) 777-7656. Website: health.wyo.gov. Contact for facility licensing, patient care standards, and data governance questions.
• Wyoming Attorney General's Office, Consumer Protection Unit: 109 State Capitol, Cheyenne, WY 82002. Phone: (307) 777-6397. Website: ag.wyo.gov. Contact for questions about the Wyoming Consumer Protection Act and state data privacy law as applied to AI.

Staying Current

Subscribe to FDA Digital Health Center of Excellence updates, ONC rulemaking notices, and the Wyoming Department of Health's administrative rules docket. The American Health Law Association and the American Medical Informatics Association both publish practical guidance on AI compliance that applies to Wyoming practitioners.

Legal Counsel

Retain Wyoming-licensed counsel with healthcare and technology experience before deploying any AI tool in a clinical setting. The intersection of FDA device law, HIPAA, Wyoming medical practice standards, and emerging consumer data privacy law creates liability exposure that generic vendor contracts do not adequately address.